These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30292939)

  • 1. A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs).
    Wang S; Gao J; Li M; Wang L; Wang Z
    Biomaterials; 2018 Dec; 187():28-38. PubMed ID: 30292939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.
    Zhang X; Yang F; Zou J; Wu W; Jing H; Gou Q; Li H; Gu J; Zou Q; Zhang J
    Vaccine; 2018 Feb; 36(8):1047-1054. PubMed ID: 29406241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Meynet E; Laurin D; Lenormand JL; Camara B; Toussaint B; Le Gouëllec A
    Vaccine; 2018 Mar; 36(14):1893-1900. PubMed ID: 29506924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.
    Zhao K; Deng X; He C; Yue B; Wu M
    Infect Immun; 2013 Dec; 81(12):4509-18. PubMed ID: 24082079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
    Maria de Souza Morais S; Ferreira Rodigues N; Ingrid Oliveira da Silva N; Aparecido Salvador E; Rodrigues Franco I; Augusto Pires de Souza G; Henrique Cruvinel da Silva P; Gustavo Nogueira de Almeida L; Prado Rocha R; Carolina Toledo da Cunha Pereira A; Portela Ferreira G; Veras Quelemes P; Pereira de Araújo M; Fornias Sperandio F; Júnia de Souza Santos L; Assis Martins Filho O; Cosme Cotta Malaquias L; Felipe Leomil Coelho L
    Vaccine; 2018 Oct; 36(43):6408-6415. PubMed ID: 30228029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Based Approach Delivers Vaccine Candidates Against
    Bianconi I; Alcalá-Franco B; Scarselli M; Dalsass M; Buccato S; Colaprico A; Marchi S; Masignani V; Bragonzi A
    Front Immunol; 2018; 9():3021. PubMed ID: 30687303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model.
    Zare Banadkoki E; Rasooli I; Ghazanfari T; Siadat SD; Shafiee Ardestani M; Owlia P
    Sci Rep; 2022 Dec; 12(1):22324. PubMed ID: 36566282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward the Elusive
    Merakou C; Schaefers MM; Priebe GP
    Surg Infect (Larchmt); 2018; 19(8):757-768. PubMed ID: 30388058
    [No Abstract]   [Full Text] [Related]  

  • 16. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine.
    Ahmadi H; Tabaraie B; Maleknia S; Pormirzagholi F; Nejati M; Hedayati MH
    J Infect Dev Ctries; 2012 Oct; 6(10):721-6. PubMed ID: 23103894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on Construction of Recombinant Bb-pGEX-
    Liu X; Li WG; Luo GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.